Table 1 CK7/CK20 immunohistochemical profile in malignant salivary gland tumors and squamous cell carcinomas

From: Immunohistochemical expression of cytokeratins 7 and 20 in malignant salivary gland tumors

Histologic type

CK7-positive cases

CK20-positive cases

CK7+/CK20+

CK7+/CK20−

CK7−/CK20+

CK7−/CK20−

MEC

26/26

2/26

2/26

24/26

0/26

0/26

 

(24 DS, 2 FS)

(2 FW)

(7.7%)

(92.3%)

(0%)

(0%)

AdCC

25/25

1/25

1/25

24/25

0/25

0/25

 

(14 DS, 11 FS)

(1 FW)

(4%)

(96%)

(0%)

(0%)

PLGA

11/11

0/11

0/11

11/11

0/11

0/11

 

(10 DS, 1 FS)

 

(0%)

(100%)

(0%)

(0%)

SDC

8/8

3/8

3/8

5/8

0/8

0/8

 

(7 DS, 1FS)

(3 FW)

(37.5%)

(62.5%)

(0%)

(0%)

ACC

4/4

0/4

0/4

4/4

0/4

0/4

 

(3 DS, 1 FS)

 

(0%)

(100%)

(0%)

(0%)

Ca-ex-MT

3/3

0/3

0/3

3/3

0/3

0/3

 

(1 DS, 2 FS)

 

(0%)

(100%)

(0%)

(0%)

NOS

3/3

0/3

0/3

3/3

0/3

0/3

 

(2 DS, 1 FS)

 

(0%)

(100%)

(0%)

(0%)

CCC

2/2

0/2

0/2

2/2

0/2

0/2

 

(2 DS)

 

(0%)

(100%)

(0%)

(0%)

BCAC

2/2

0/2

0/2

2/2

0/2

0/2

 

(2 DS)

 

(0%)

(100%)

(0%)

(0%)

All MSGT

84/84

6/84

6/84

78/84

0/84

0/84

 

(65 DS, 19 FS)

(6 FW)

(7.1%)

(92.9%)

(0%)

(0%)

SCCa

4/13

0/13

0/13

4/13

0/13

9/13

 

(4 FW)

 

(0%)

(30.8%)

(0%)

(69.2%)

  1. Abbreviations: MSGT, malignant salivary gland tumor; SCCa, squamous cell carcinoma; MEC, mucoepidermoid carcinoma; AdCC, adenoid cystic carcinoma; PLGA, polymorphous low-grade adenocarcinoma; SDC, salivary duct carcinoma; ACC, acinic cell carcinoma; Ca-ex-MT, carcinoma ex mixed tumor; NOS, adenocarcinoma not otherwise specified; CCC, clear cell carcinoma; BCAC, basal cell adenocarcinoma; DS, diffuse strong; FS, focal strong; FW, focal weak.